JACQUELINE MEREDAY: Open Payments
NPI 1285855841 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 39 payments from 10 companies in 2025. Trend: 2023 $821 · 2024 $773 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $217 |
| ABBVIE INC. | 10 | $161 |
| Novo Nordisk Inc | 1 | $122 |
| Gilead Sciences, Inc. | 4 | $95 |
| Ardelyx, Inc. | 4 | $93 |
| Madrigal Pharmaceuticals | 3 | $85 |
| Janssen Biotech, Inc. | 2 | $46 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
Products named: XIFAXAN, RINVOQ, Wegovy, IBSRELA, REZDIFFRA, TREMFYA, TERLIVAZ, OCALIVA.
Industry payments across NY — which companies pay providers there.
